Otsuka Holdings Co., Ltd. (TYO:4578)
Japan flag Japan · Delayed Price · Currency is JPY
7,087.00
+48.00 (0.68%)
Jun 27, 2025, 3:30 PM JST

Revenue by Product

Fiscal year is January - December.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 2012 - 2020
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Dec '21 2012 - 2020
Pharmaceuticals
1,687.26B
Log In
Log In
Log In
Log In
Upgrade
Pharmaceuticals Growth
17.07%
Log In
Log In
Log In
Log In
Upgrade
Nutraceuticals
562.14B
Log In
Log In
Log In
Log In
Upgrade
Nutraceuticals Growth
11.19%
Log In
Log In
Log In
Log In
Upgrade
Consumer Products
33.86B
Log In
Log In
Log In
Log In
Upgrade
Consumer Products Growth
-6.24%
Log In
Log In
Log In
Log In
Upgrade
Other Segment
109.93B
Log In
Log In
Log In
Log In
Upgrade
Other Segment Growth
2.91%
Log In
Log In
Log In
Log In
Upgrade
Other Revenue seg1
1.00M
Log In
Log In
Log In
Log In
Upgrade
Other Revenue seg1 Growth
-
Log In
Log In
Log In
Log In
Upgrade

EBIT by Product

Fiscal year is January - December.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 2012 - 2020
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Dec '21 2012 - 2020
Pharmaceuticals Segment Profit
321.90B
Log In
Log In
Log In
Log In
Upgrade
Pharmaceuticals Segment Profit Growth
114.82%
Log In
Log In
Log In
Log In
Upgrade
Nutraceuticals Segment Profit
58.56B
Log In
Log In
Log In
Log In
Upgrade
Nutraceuticals Segment Profit Growth
45.46%
Log In
Log In
Log In
Log In
Upgrade
Consumer Products Segment Profit
23.89B
Log In
Log In
Log In
Log In
Upgrade
Consumer Products Segment Profit Growth
67.84%
Log In
Log In
Log In
Log In
Upgrade
Other Segment Profit
7.41B
Log In
Log In
Log In
Log In
Upgrade
Other Segment Profit Growth
-883.09%
Log In
Log In
Log In
Log In
Upgrade
Eliminations from Segment Profit
-55.79B
Log In
Log In
Log In
Log In
Upgrade
Eliminations from Segment Profit Growth
14.94%
Log In
Log In
Log In
Log In
Upgrade
Other EBIT seg1
93.35B
Log In
Log In
Log In
Log In
Upgrade
Other EBIT seg1 Growth
-37.86%
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 2012 - 2020
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Dec '21 2012 - 2020
Japan
698.20B
Log In
Log In
Log In
Log In
Upgrade
Japan Growth
2.38%
Log In
Log In
Log In
Log In
Upgrade
North America
1,152.50B
Log In
Log In
Log In
Log In
Upgrade
North America Growth
25.20%
Log In
Log In
Log In
Log In
Upgrade
Europe
246.40B
Log In
Log In
Log In
Log In
Upgrade
Europe Growth
10.79%
Log In
Log In
Log In
Log In
Upgrade
Others
296.10B
Log In
Log In
Log In
Log In
Upgrade
Others Growth
11.74%
Log In
Log In
Log In
Log In
Upgrade

Other

Fiscal year is January - December.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 2012 - 2020
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Dec '21 2012 - 2020
Pharmaceuticals Business Profit
427.65B
Log In
Log In
Log In
Log In
Upgrade
Pharmaceuticals Business Profit Growth
46.63%
Log In
Log In
Log In
Log In
Upgrade
Nutraceuticals Business Profit
62.31B
Log In
Log In
Log In
Log In
Upgrade
Nutraceuticals Business Profit Growth
-10.90%
Log In
Log In
Log In
Log In
Upgrade
Consumer Products Business Profit
24.13B
Log In
Log In
Log In
Log In
Upgrade
Consumer Products Business Profit Growth
10.96%
Log In
Log In
Log In
Log In
Upgrade
Other Segment Business Profit
6.84B
Log In
Log In
Log In
Log In
Upgrade
Other Segment Business Profit Growth
-7.00%
Log In
Log In
Log In
Log In
Upgrade
Eliminations from Business Profit
-56.48B
Log In
Log In
Log In
Log In
Upgrade
Eliminations from Business Profit Growth
11.80%
Log In
Log In
Log In
Log In
Upgrade